A cancer screening method is provided, wherein the method is characterized by administering a compound to a patient, the compound being a complex of a fluorescent marker and a radioactive marker, in a dose emitting between 5 Gy and 20 Gy radiation. Cells are then collected preferably through non-invasive or minimally invasive means. If fluorescence is observed in the exfoliated cells, tomographic scanning is conducted to further locate and/or confirm suspected malignant areas or metastatic areas. Further observation or treatment may be conducted either through fluorescence guided endoscopy, photo-dynamic therapy, and/or radiation treatment.

 
Web www.patentalert.com

< PRO788 polypeptides

< Process of making a compound by forming a polymer from a template drug

> Collection device for lateral flow chromatography

> Polysaccharide extract of Dioscorea sp. and an orally active pharmaceutical composition comprising the same

~ 00230